Stocks to sell

This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here. 2023 has been an incredible year for the stock market. The Nasdaq Composite has risen 34% so far, its best showing since 1983. The macro picture is looking bright, with inflation on the retreat
0 Comments
As much as I love good dividend stocks, I have very little patience for F-rated dividend stocks that do nothing but drag your portfolio down. As an investor, you deserve better! A great dividend stock can make all the difference in your portfolio. By reinvesting dividends, growth investors can increase their positions and investing power
0 Comments
The U.S. equity valuations continue their remarkable trend upward, well beyond anyone’s expectations in 2023. The major indices appreciated amid expectations of a soft landing for the economy as the Federal Reserve battles inflation. While inflation still sits above the Federal Reserve’s target, it is well below where it was 12 months ago. However, despite
0 Comments
Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high risk, that is not necessarily the case here with CMRX stock. Sure, on paper, Chimerix’s future prospects appear very promising. Last year, the company sold a treatment that
0 Comments
Some of the top companies on the market just posted poor second-quarter financial results. While company executives always do their best to put a positive spin on their quarterly numbers. there’s no covering up a truly awful print. That includes these seven stocks to avoid after Q2 earnings. Stocks to Avoid After Q2 Earnings: Roblox (RBLX) Source: Michael
0 Comments
Investing in growth stocks can be risky, especially for those migrating into new markets or turnaround ventures. Personally, I’ve experienced losses from such endeavors. Amid rising interest rates, caution is advised for overpriced growth stocks. Despite recent declines, their valuations remain risky. Two factors contribute to their potential downfall: further interest rate hikes and underwhelming
0 Comments